Indicted Insys Execs Face October 2018 Trial

By Rachel Graf (September 12, 2017, 5:32 PM EDT) -- A Massachusetts federal judge on Tuesday set an Oct. 15, 2018, trial date for six former Insys Therapeutics Inc. executives and managers accused of bribing doctors to prescribe a spray version of the opioid fentanyl intended to treat cancer pain, often to patients without cancer.

At a Boston status conference, U.S. District Judge Allison D. Burroughs set the date for an estimated 10-week trial for Michael L. Babich, Alec Burlakoff, Michael J. Gurry, Richard M. Simon, Sunrise Lee and Joseph A. Rowan.

"We are looking forward to our opportunity to establish the innocence of our client at trial," Joseph Sedwick Sollers...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!